Kedrion Biopharma

📍 Italy🗓 Founded 2001👥 1,168 employees💰 Last funded Mar 2004
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2001
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Kedrion Biopharma?
Kedrion Biopharma has 1 investor on record on gritt.io, 1 mid-stage.
When did Kedrion Biopharma last raise funding?
The most recent investment in Kedrion Biopharma recorded on gritt.io was in March 2004.
When was Kedrion Biopharma founded?
Kedrion Biopharma was founded in 2001.
What industry is Kedrion Biopharma in?
Kedrion Biopharma operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Kedrion Biopharma based?
Kedrion Biopharma is headquartered in Italy.